Published in J Biol Chem on July 05, 1993
Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2. Nat Cell Biol (2007) 2.70
ER beta inhibits proliferation and invasion of breast cancer cells. Endocrinology (2001) 2.18
Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways. J Mol Endocrinol (2008) 1.89
Loss of ERbeta expression as a common step in estrogen-dependent tumor progression. Endocr Relat Cancer (2004) 1.84
Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action. Br J Cancer (2004) 1.72
Prolactin and estrogen enhance the activity of activating protein 1 in breast cancer cells: role of extracellularly regulated kinase 1/2-mediated signals to c-fos. Mol Endocrinol (2005) 1.06
Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones. Endocr Relat Cancer (2000) 1.06
Relationship between tamoxifen-induced transforming growth factor beta 1 expression, cytostasis and apoptosis in human breast cancer cells. Br J Cancer (1995) 1.05
Stable transfection of protein kinase C alpha cDNA in hormone-dependent breast cancer cell lines. Br J Cancer (2000) 1.03
Multiple domains of the Receptor-Interacting Protein 140 contribute to transcription inhibition. Nucleic Acids Res (2004) 1.01
Dynamic, large-scale profiling of transcription factor activity from live cells in 3D culture. PLoS One (2010) 0.97
A transcriptional enhancer required for the differential expression of the human estrogen receptor in breast cancers. Mol Cell Biol (1997) 0.96
Antiestrogens--tamoxifen, SERMs and beyond. Invest New Drugs (1999) 0.95
The oestrogen-like effect of 4-hydroxytamoxifen on induction of transforming growth factor alpha mRNA in MDA-MB-231 breast cancer cells stably expressing the oestrogen receptor. Br J Cancer (1998) 0.91
IQGAP1 binds to estrogen receptor-α and modulates its function. J Biol Chem (2014) 0.86
Scribble modulates the MAPK/Fra1 pathway to disrupt luminal and ductal integrity and suppress tumour formation in the mammary gland. PLoS Genet (2014) 0.86
Oestrogen and growth factor cross-talk and endocrine insensitivity and acquired resistance in breast cancer. Br J Cancer (2000) 0.85
Breaking the cycle: An insight into the role of ERα in eukaryotic cell cycles. J Carcinog (2011) 0.81
Distinct transcriptional regulation of human large conductance voltage- and calcium-activated K+ channel gene (hSlo1) by activated estrogen receptor alpha and c-Src tyrosine kinase. J Biol Chem (2011) 0.77
Estrogen receptor beta and truncated variants enhance the expression of transfected MMP-1 promoter constructs in response to specific mechanical loading. Biol Sex Differ (2014) 0.76
Molecular Cloning and Characterization of the Estrogen Receptor from the Striped Bitterling (Acheilognathus yamatsutae). Environ Health Toxicol (2011) 0.75
A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Cell (1980) 2.28
Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res (2001) 2.21
Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth. Cancer Res (1982) 2.15
Inhibition of breast cancer growth by suramin. J Natl Cancer Inst (1992) 2.10
Cathepsin D: an independent prognostic factor for metastasis of breast cancer. Lancet (1989) 1.77
Estradiol induced proteins in the MCF7 human breast cancer cell line. Biochem Biophys Res Commun (1979) 1.76
Cathepsin D immunostaining in paraffin-embedded breast cancer cells and macrophages: correlation with cytosolic assay. Hum Pathol (1994) 1.52
Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein. Endocrinology (1986) 1.50
Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells. Proc Natl Acad Sci U S A (1992) 1.48
Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer. Cancer Res (1989) 1.48
Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency. Oncogene (1990) 1.47
Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis. Cancer Res (1998) 1.37
Overexpression of p21WAF1/CIP1 induces growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines. Oncogene (1995) 1.35
Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells. Cancer Res (1989) 1.34
Steroid receptor-mediated cytotoxicity of an antiestrogen and an antiprogestin in breast cancer cells. Cancer Res (1987) 1.33
Breast cancer cells have a high capacity to acidify extracellular milieu by a dual mechanism. Clin Exp Metastasis (1997) 1.32
Effects of antiestrogens on the estrogen-regulated pS2 RNA and the 52- and 160-kilodalton proteins in MCF7 cells and two tamoxifen-resistant sublines. J Biol Chem (1984) 1.31
In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells. Cancer Res (1988) 1.30
Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens. Biochem Biophys Res Commun (1987) 1.29
Estrogens stimulate cell proliferation and induce secretory proteins in a human breast cancer cell line (T47D). J Clin Endocrinol Metab (1982) 1.20
Hydroxylated metabolites of tamoxifen are formed in vivo and bound to estrogen receptor in target tissues. J Biol Chem (1981) 1.20
Effects of plasma estrogen sulfates in mammary cancer cells. Endocrinology (1980) 1.20
A mutated cathepsin-D devoid of its catalytic activity stimulates the growth of cancer cells. Oncogene (2001) 1.19
MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D. Exp Cell Res (1991) 1.19
Breast cancer cell invasiveness: correlation with protein kinase C activity and differential regulation by phorbol ester in estrogen receptor-positive and -negative cells. Int J Cancer (1998) 1.18
Characterization of the physical interaction between estrogen receptor alpha and JUN proteins. J Biol Chem (2001) 1.17
FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells. Mol Endocrinol (1998) 1.17
Expression of human sequences related to those of mouse mammary tumor virus. J Virol (1988) 1.16
Cloning and sequencing of the 52K cathepsin D complementary deoxyribonucleic acid of MCF7 breast cancer cells and mapping on chromosome 11. Mol Endocrinol (1988) 1.15
Estrogens and growth factors induce the mRNA of the 52K-pro-cathepsin-D secreted by breast cancer cells. Nucleic Acids Res (1988) 1.15
Characterization of the proximal estrogen-responsive element of human cathepsin D gene. Mol Endocrinol (1994) 1.14
Phosphorylation, glycosylation, and proteolytic activity of the 52-kD estrogen-induced protein secreted by MCF7 cells. J Cell Biol (1987) 1.13
The 52-kDa estrogen-induced protein secreted by MCF7 cells is a lysosomal acidic protease. Biochem Biophys Res Commun (1986) 1.12
Differential interaction of nuclear receptors with the putative human transcriptional coactivator hTIF1. J Biol Chem (1997) 1.11
Cathepsin D in breast cancer cells can digest extracellular matrix in large acidic vesicles. Cancer Res (1990) 1.10
Estrogens increase the expression of fibulin-1, an extracellular matrix protein secreted by human ovarian cancer cells. Proc Natl Acad Sci U S A (1996) 1.10
SKOV3 ovarian carcinoma cells have functional estrogen receptor but are growth-resistant to estrogen and antiestrogens. J Steroid Biochem Mol Biol (1995) 1.09
Effect of estradiol on the ultrastructure of the MCF7 human breast cancer cells in culture. Cancer Res (1982) 1.08
Why are estrogen-receptor-negative breast cancers more aggressive than the estrogen-receptor-positive breast cancers? Invasion Metastasis (1995) 1.08
Characterization of very acidic phagosomes in breast cancer cells and their association with invasion. J Cell Sci (1994) 1.07
Estradiol and fibulin-1 inhibit motility of human ovarian- and breast-cancer cells induced by fibronectin. Int J Cancer (1998) 1.06
Regulation of cathepsin-D and pS2 gene expression by growth factors in MCF7 human breast cancer cells. Mol Endocrinol (1989) 1.05
Unliganded and liganded estrogen receptors protect against cancer invasion via different mechanisms. Mol Endocrinol (2000) 1.05
Mouse mammary tumour virus related sequences are present in human DNA. Nucleic Acids Res (1983) 1.04
High-affinity binding to the estrogen receptor of [3H]4-hydroxytamoxifen, an active antiestrogen metabolite. Mol Cell Endocrinol (1980) 1.02
Biological and clinical significance of cathepsin D in breast cancer metastasis. Stem Cells (1996) 1.02
A prospective study of the prognostic value of cathepsin D levels in breast cancer cytosol. Cancer (1993) 1.02
Steroid hormone receptors. Vitam Horm (1975) 1.00
The prognostic value of cathepsin D in breast cancer. A long road to the clinic. Eur J Cancer (1996) 0.99
Retinoid-resistant estrogen receptor-negative human breast carcinoma cells transfected with retinoic acid receptor-alpha acquire sensitivity to growth inhibition by retinoids. J Biol Chem (1994) 0.99
Transfected cathepsin D stimulates high density cancer cell growth by inactivating secreted growth inhibitors. Cell Growth Differ (1995) 0.99
Increased cathepsin D level in the serum of patients with metastatic breast carcinoma detected with a specific pro-cathepsin D immunoassay. Cancer (1997) 0.99
Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cells. Proc Natl Acad Sci U S A (1993) 0.98
Dual effects of the progestin R5020 on proteins released by the T47D human breast cancer cells. J Biol Chem (1984) 0.98
Formation of estrogen nuclear receptor in uterus: effect of androgens, estrone and nafoxidine. Biochem Biophys Res Commun (1972) 0.98
Fatty acid synthetase and its mRNA are induced by progestins in breast cancer cells. J Biol Chem (1987) 0.98
Metabolism and protein binding of sex steroids in target organs: an approach to the mechanism of hormone action. Recent Prog Horm Res (1971) 0.97
In vivo effect of anti-estrogens on the localisation and replenishment of estrogen receptor. Mol Cell Endocrinol (1975) 0.96
Differences between oestrogen receptor activation by oestrogen and antioestrogen. Nature (1981) 0.96
Characterization of monoclonal antibodies to the estrogen-regulated Mr 52,000 glycoprotein and their use in MCF7 cells. Cancer Res (1985) 0.96
Estradiol stimulates cell growth and secretion of procathepsin D and a 120-kilodalton protein in the human ovarian cancer cell line BG-1. J Clin Endocrinol Metab (1992) 0.95
The antiprogestin RU486 in advanced breast cancer: preliminary clinical trial. Bull Cancer (1987) 0.95
[Hormone receptors: relations between the cytoplasmic 8 S, cytoplasmic 4 S, and nuclear uterine receptors of estradiol]. C R Acad Sci Hebd Seances Acad Sci D (1968) 0.95
Cathepsin D assay in primary breast cancer and lymph nodes: relationship with c-myc, c-erb-B-2 and int-2 oncogene amplification and node invasiveness. Eur J Cancer (1990) 0.94
The PKCθ pathway participates in the aberrant accumulation of Fra-1 protein in invasive ER-negative breast cancer cells. Oncogene (2012) 0.94
Antiestrogenic effect of R5020, a synthetic progestin in human breast cancer cells in culture. J Clin Endocrinol Metab (1983) 0.94
Hormonal regulation of cathepsin D following transfection of the estrogen or progesterone receptor into three sex steroid hormone resistant cancer cell lines. J Steroid Biochem Mol Biol (1991) 0.93
Estrogenic effects of physiological concentrations of 5-androstene-3 beta, 17 beta-diol and its metabolism in MCF7 human breast cancer cells. Cancer Res (1981) 0.93
Dissociated overexpression of cathepsin D and estrogen receptor alpha in preinvasive mammary tumors. Hum Pathol (2000) 0.93
New in vitro studies of estradiol binding in castrated rat uterus. Endocrinology (1969) 0.93
Chromatin structure of the regulatory regions of pS2 and cathepsin D genes in hormone-dependent and -independent breast cancer cell lines. Oncogene (1999) 0.92
Specific mannose-6-phosphate receptor-independent sorting of pro-cathepsin D in breast cancer cells. Exp Cell Res (1994) 0.92
Interactions of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II. Mol Endocrinol (1990) 0.92
Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast-cancer cells. Int J Cancer (1994) 0.91
Endocytosis of pro-cathepsin D into breast cancer cells is mostly independent of mannose-6-phosphate receptors. J Cell Sci (1998) 0.90
Identification and androgen regulation of two proteins released by T47D human breast cancer cells. Cancer Res (1987) 0.90
Cathepsin D maturation and its stimulatory effect on metastasis are prevented by addition of KDEL retention signal. Oncogene (1994) 0.90
Differential regulation of cathepsin D by sex steroids in mammary cancer and uterine cells. Mol Cell Endocrinol (1989) 0.89
Cathepsin D concentration in breast cancer cytosols: correlation with biochemical, histological, and clinical findings. Clin Chem (1991) 0.89
The estrogenic and antiestrogenic activities of androgens in female target tissues. Pharmacol Ther (1983) 0.89
Progestin increases gene transcription and messenger ribonucleic acid stability of fatty acid synthetase in breast cancer cells. Mol Endocrinol (1989) 0.89
In vitro binding of the estrogen receptor to DNA: absence of saturation at equilibrium. FEBS Lett (1975) 0.89
Increased immunostaining of fibulin-1, an estrogen-regulated protein in the stroma of human ovarian epithelial tumors. Am J Pathol (1998) 0.89
Effects of progestins and menstrual cycle on fatty acid synthetase and progesterone receptor in human mammary glands. J Clin Endocrinol Metab (1990) 0.88
Progestin-induced fatty acid synthetase in human mammary tumors: from molecular to clinical studies. J Steroid Biochem Mol Biol (1992) 0.88
Purification and first characterization of the secreted and cellular 52-kDa proteins regulated by estrogens in human-breast cancer cells. Eur J Biochem (1986) 0.87
Cathepsin D gene of human MCF7 cells contains estrogen-responsive sequences in its 5' proximal flanking region. Biochem Biophys Res Commun (1991) 0.87
[Estrogen-induced proteins secreted by MCF7 human breast cancer cells stimulate their proliferation]. C R Seances Acad Sci III (1983) 0.87
Estradiol increases the production of alpha 1-antichymotrypsin in MCF7 and T47D human breast cancer cell lines. Mol Cell Endocrinol (1985) 0.86
Cathepsin-D in human endometrium: induction by progesterone and potential value as a tumor marker. J Clin Endocrinol Metab (1990) 0.86
Analysis of the potential contribution of estrogen receptor (ER) beta in ER cytosolic assay of breast cancer. Int J Cancer (2001) 0.86